Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. - Wikidata - awgldk - TriplyDB

Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.

Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.

http://www.wikidata.org/entity/Q30488297

about

Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinoma The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update Genome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, China Identification and characterization of tropomyosin 3 associated with granulin-epithelin precursor in human hepatocellular carcinoma Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancers High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma.Tropomyosin3 overexpression and a potential link to epithelial-mesenchymal transition in human hepatocellular carcinoma.Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.The motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinoma AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells.Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.Common variants at the promoter region of the APOM confer a risk of rheumatoid arthritis Genomic losses at 5q13.2 and 8p23.1 in dysplastic hepatocytes are common events in hepatitis B virus-related hepatocellular carcinoma Aneuploidy as a mechanism for stress-induced liver adaptation.Up-regulation of KIF14 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in cervical cancer Aberrant Promoter Methylation at CpG Cytosines Induce the Upregulation of the E2F5 Gene in Breast Cancer Integrated analysis of copy number alteration and RNA expression profiles of cancer using a high-resolution whole-genome oligonucleotide array.Keratin 18-deficiency results in steatohepatitis and liver tumors in old mice: A model of steatohepatitis-associated liver carcinogenesis.Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches.An Overview of Biomarkers and Molecular Signatures in HCC.1p36.22 region containing PGD gene is frequently gained in human cervical cancer.TPM3, a strong prognosis predictor, is involved in malignant progression through MMP family members and EMT-like activators in gliomas.Suppression of KIF14 expression inhibits hepatocellular carcinoma progression and predicts favorable outcome.KIF14 as an oncogene in retinoblastoma: a target for novel therapeutics?A potential oncogenic role of the commonly observed E2F5 overexpression in hepatocellular carcinoma.Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma.Oncogenetic tree modeling of human hepatocarcinogenesis.Recurrent loss of the FHIT gene and its impact on lymphatic metastasis in early oral squamous cell carcinoma.Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.Kinesin family member 14 in human oral cancer: A potential biomarker for tumoral growth.Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3.Sox17 inhibits hepatocellular carcinoma progression by downregulation of KIF14 expression.Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14

P2860

Q24298070-1499884D-EC23-42AE-9DA2-0F9FD9969C1B Q27003050-0545DBFB-AA05-4CBD-9090-F06066C86575 Q28538135-912B5556-5733-4F50-BF36-973F8219A342 Q28727430-18B92A8F-BB16-4E9D-A4C3-372AF27E6980 Q30489312-DEAF5E02-B9CC-4FF4-B4DA-25DDC649A82E Q30873773-867BAFE2-3F16-45A0-9305-20707FFE5670 Q31043530-DAF6E4CB-A033-4280-B9C9-7811BE3DBA95 Q33548174-019A8AA6-0FA8-4D4D-A15C-B4C55B6AA19F Q33715938-104068E9-FB3B-402A-91A9-5AC157C07DFC Q34287768-E3CFF604-079B-40AC-B1EF-09A573A6D201 Q34692260-02676245-2F24-455F-A9CC-D8A694FD0B4E Q34836194-85F014BA-A9E2-414E-9273-BE2C1FB6B042 Q34998666-4CA37809-FD8B-440C-AAFA-0AFF59EFDCD4 Q35120277-A00DA1CF-E3BA-4459-9E76-EEB0E55E9565 Q35212779-6CD0754F-C702-4F0E-A110-FBBCEDFB8098 Q35645759-BE135F3C-0509-4E21-B514-B2E230DA90B3 Q35759029-0E24F79F-5BBB-4047-B806-2F0EAB0279B9 Q36190750-B4708D07-9C3D-41AF-AECC-DF189C6E5FB1 Q36765087-0FBB4758-B294-4D61-B792-634073BC41A0 Q37056909-901B4D80-D1C7-41FA-83D1-05A0C2AEDF12 Q37290013-9135E2D2-61C7-4DD8-99E8-92C50A14D896 Q37687384-82F4A3A9-8365-476C-ACFB-AC452B389F55 Q37857056-E5DDB2ED-FD27-4B31-9CD4-EE0D2EEA1B34 Q38166571-556FD901-87AD-4464-B68E-0F6A712673B9 Q38446093-3D424BFB-F5A1-411D-AC47-A1126263CAD9 Q38986381-31651282-8DCC-4C9F-8607-49922FF0C8D1 Q39193699-422D7479-9349-485E-9C41-2AA418031BFE Q39512476-1EE4F77D-168D-4F1A-BD8A-DDE4E4AD2F70 Q39601497-68AC2A2A-0442-4884-964D-2025761A75A2 Q40493175-37E425A6-6821-4CF5-B5C7-B56C619880C5 Q43035203-A5F238E9-EBC0-4769-84DB-66D49360EA78 Q45023178-F7B9D4F9-7BB5-4514-9DFC-60CD0C933D8C Q45087026-A75FD8C7-075A-45CD-AAB6-81126D22499A Q47094090-B4928416-7766-4D34-91D7-038634BB3F87 Q47266195-5074BDD7-AC18-434B-BD0A-90A9E2EE7323 Q51064043-D647BC35-18A4-44CB-AD9E-BD2794A8A6B2 Q58370838-94CAB59E-50D7-4914-ADCD-6142BCA48207

P2860

Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.

http://www.wikidata.org/entity/Q30488297

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Clinical implication of recurr ...... enes in recurrent gains on 1q.

@ast

Clinical implication of recurr ...... enes in recurrent gains on 1q.

@en

type

label

Clinical implication of recurr ...... enes in recurrent gains on 1q.

@ast

Clinical implication of recurr ...... enes in recurrent gains on 1q.

@en

prefLabel

Clinical implication of recurr ...... enes in recurrent gains on 1q.

@ast

Clinical implication of recurr ...... enes in recurrent gains on 1q.

@en

P1433

Q30488297-B25D0CD3-7605-41FF-B6D6-5D151C436C63

P1476

Q30488297-0CA894C8-0CA9-4D1D-B844-F64DE243ABB1

P2093

Q30488297-0E30F255-9399-4155-91BF-9966CB4537BE

Q30488297-0E9589F6-AE34-4BFE-812D-5280B1DD89C4

Q30488297-10FB6CE9-3F64-4799-B127-31ABE2054BCB

Q30488297-43DC6FEC-DD9C-4DD2-A56F-65A5001FAB1E

Q30488297-4623F018-D116-4352-957F-460548CD80BC

Q30488297-496DA085-D192-4E6E-8666-162E5BDDE2D8

Q30488297-5179BF84-D32D-400A-8A45-7DD8A894CBC6

Q30488297-5C465705-E475-4718-9AF2-E6489E30B9B0

Q30488297-6ED43F87-AA6B-45D4-B386-A09706F87E19

Q30488297-9F6FFEC6-3043-443D-8782-B33AE2C1E3D1

P2860

Q30488297-008CC8AF-24C2-4D58-85A2-348C2E0107F8

Q30488297-06B2827E-E988-4D2F-A4EF-25B6DCA4744E

Q30488297-11B75196-487E-4B65-8609-B5630DBD4E13

Q30488297-153C3721-84B7-45B6-B7EA-9BE547811E4E

Q30488297-16991515-854E-418F-BE48-4999BBB138C1

Q30488297-1700CE87-36C5-4DCD-90DF-4BC3CF6BF7E4

Q30488297-1BD17E42-CB54-4C7F-996B-D071E9D0355D

Q30488297-26E64127-05B0-4DB8-A53D-D0D56FB8212D

Q30488297-2B5B8B12-4427-4A7F-BE0B-2A6788F10AA9

Q30488297-429DA740-913F-4EC1-83E8-6B4CD53EC94E

P304

Q30488297-C78ABF3B-5110-4141-A1AF-F7E8C9EACCEC

P31

Q30488297-2E00B2F9-0FEC-4B42-891A-8D64DC3A66BA

P356

Q30488297-AB6F4BE3-17CF-456D-A3FA-7077F8164825

P433

Q30488297-97907E22-5D07-4B36-9DB8-6668C8D79D91

P478

Q30488297-9C3791B0-92C8-46FE-ADF6-F1BA24A22631

P577

Q30488297-E2E2E5C3-F4BF-4B29-975B-06370B960399

P5875

Q30488297-506F47FF-79BC-4DFA-ACBD-6541EAC6A62B

P698

Q30488297-94FF25BE-79C8-415F-B510-71BEE002E361

P932

Q30488297-B57D259F-AFD7-45A1-9A28-EEFB8D62CBD9

P356

P1433

International Journal of Cancer

P1476

Clinical implication of recurr ...... enes in recurrent gains on 1q.

@en

P2093

Cheol-Keun Park

http://www.w3.org/2001/XMLSchema#string

Hai-Dong Xu

http://www.w3.org/2001/XMLSchema#string

Heike Fiegler

http://www.w3.org/2001/XMLSchema#string

Jong-Young Choi

http://www.w3.org/2001/XMLSchema#string

Mi-Seon Kwon

http://www.w3.org/2001/XMLSchema#string

Mun-Gan Rhyu

http://www.w3.org/2001/XMLSchema#string

Nigel P Carter

http://www.w3.org/2001/XMLSchema#string

Seon-Hee Yim

http://www.w3.org/2001/XMLSchema#string

Seung-Hun Shin

http://www.w3.org/2001/XMLSchema#string

Tae-Min Kim

http://www.w3.org/2001/XMLSchema#string

P2860

KIF14 and citron kinase act together to promote efficient cytokinesis

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

The Gene Ontology (GO) database and informatics resource

The KEGG databases at GenomeNet.

PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas

TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas

KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers

Tropomyosin isoforms: divining rods for actin cytoskeleton function

KIF14 mRNA expression is a predictor of grade and outcome in breast cancer

Hepatocellular carcinoma

P304

2808-2815

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.23901

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23268402

http://www.w3.org/2001/XMLSchema#string

P698

18803288

http://www.w3.org/2001/XMLSchema#string

P932

2698448

http://www.w3.org/2001/XMLSchema#string